are glp 1 controlled substances GLP-1 for Weight Loss and Diabetes Originally developed as diabetes drugs,

Metabolic N-dealkylation and N-oxidation as elucidators of the role of alkylamino moieties in drugs acting at various receptors

Khadir F, Pouramir M, Joorsaraee SG, Feizi F, Sorkhi H, Yousefi F

Gut healing may show results within 2-4 weeks

YY: Resources, Writing original draft

Many have found weight-loss success using GLP-1 agonists, but like most medications, they come with side effects, and any results seen last only as long as medication continues

The "minimal initial benefit" group (approximately 5-10% of users) reported limited improvements during treatment making discontinuation effects irrelevant, typically explained by inadequate product quality with degraded or low-concentration GHK-Cu, inappropriate application technique reducing absorption, unrealistic expectations exceeding what any topical can achieve, severe underlying pathology requiring medical intervention beyond cosmetic peptides, or individual non-responsiveness to copper peptide treatment for genetic or physiological reasons